Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
10/2010
10/21/2010US20100267963 Method of producing 2-alkyl-3-aminothiophene derivative
10/21/2010US20100267780 Bicyclic aryl and heteroaryl receptor modulators
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/21/2010US20100267676 Gamma-amino-butyric acid derivatives as gabab receptor ligands
10/21/2010CA2758245A1 Gamma-amino-butyric acid derivatives as gabab receptor ligands
10/21/2010CA2757573A1 Substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carbonitriles and substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carboxamides as tubulin polymerization inhibitors
10/20/2010EP2241563A1 Tri-substituted aromatic compound
10/20/2010EP2240462A1 Therapeutic compounds
10/20/2010EP2240450A1 Trpa1 antagonists
10/20/2010EP2240029A1 Compounds for inflammation and immune-related uses
10/20/2010EP1899299B1 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
10/20/2010EP1569929B9 Compounds and methods for the treatment or prevention of flavivirus infections
10/20/2010EP1317431B1 Polyarylcarboxamides useful as lipid lowering agents
10/20/2010CN101863923A Novel inhibitors of chymase
10/19/2010US7816558 Triarylcarboxylic acid derivative
10/19/2010US7816536 4-substituted and 7-substituted indoles, benzofurans, benzothiophenes, benzimidazoles, benzoxazoles, and benzothiazoles and methods for making same
10/19/2010US7816408 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
10/19/2010US7816397 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
10/19/2010CA2464367C Bicyclic compounds
10/19/2010CA2447440C Chloromethylation of thiophene
10/19/2010CA2436526C Heterocyclic sulfonamide inhibitors of beta amyloid production
10/19/2010CA2433417C Novel 1,2-diphenylethene derivatives for treatment of immune diseases
10/14/2010WO2010115952A1 Indane derivatives
10/14/2010US20100261910 Process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates
10/14/2010US20100261900 Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates
10/14/2010US20100261775 Polymorphic form of duloxetine hydrochloride
10/14/2010US20100261760 EP2 Receptor Agonists
10/14/2010US20100261727 2-arylbenzothiophene derivatives or pharceutically acceptable salts thereof, preparation method thereof, and pharceutical composition for the diagnosis or treatment of degenerative brain disease containing the same as active ingredient
10/14/2010US20100261725 Compounds that modulate intracellular calcium
10/14/2010US20100261675 Fungicidal composition containing acid amide derivative
10/14/2010US20100260778 Small-molecule botulinum toxin inhibitors
10/14/2010CA2758105A1 Indane derivatives
10/13/2010EP1255553B1 Use of trilostane or keto-trilostane in combination with an antioestrogen in the treatment of a hormone-dependent condition.
10/13/2010CN1939922B 5H-thiophene [3,4-C] pyrrole-4,6-diketone derivative for inhibiting cell release tumor necrosis factor
10/13/2010CN1916760B Acid-producing agent, sulfonic acid, sulfonic acid derivative and radiation-sensitive resin composition
10/13/2010CN101857587A 2-aryl benzothiophene derivatives or pharmaceutically acceptable salts thereof, preparation method thereof, and phrmaceutical composition for the diagnosis or treatment of degenerative brain disease containing the same as an active ingredient
10/13/2010CN101857586A Anti-racemization preparation method of D-(+)-alpha-(2-thienylethamino)-alpha-(2-chlorophenyl) acetate hydrochloride
10/13/2010CN101857547A Preparation method of 2-nitro-1-aryl alcohol
10/12/2010CA2531543C Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
10/12/2010CA2480038C Substituted 4-aminocyclohexanols
10/12/2010CA2339761C Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
10/07/2010WO2010114107A1 Actinic ray-sensitive or radiation-sensitive resin composition and pattern forming method using the same
10/07/2010WO2010113022A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010US20100256396 Aromatic compound
10/07/2010US20100256201 Cell differentiation inducer
10/07/2010US20100256165 Large conductance calcium-activated k channel opener
10/07/2010US20100256156 Heterocyclic compound
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100255106 Benzothiophenes, formulations containing same, and methods
10/07/2010US20100255054 Pharmaceutical composition for treatment and prevention of restenosis
10/07/2010CA2757615A1 Plasminogen activator inhibitor-1 inhibitor
10/06/2010EP2234993A1 Bis- (sulf onylamino) derivatives for use in therapy
10/06/2010EP1910325B1 New pharmaceutical compounds
10/06/2010CN1921170B Organic semiconductor material, organic semiconductor element and field effect transistor using the same
10/06/2010CN101855201A Oxime esters and photopolymerization initiators containing the same
10/06/2010CN101851244A Substituted phenyl keto enols as pesticides and herbicides
10/06/2010CN101851228A Method for preparing polysubstituted thiophene derivative
10/06/2010CN101851211A Novel piperazinoamide compound
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/06/2010CN101851168A Process for the preparation of N-monosubstituted beta-amino alcohols
10/06/2010CN101849953A Inflammatory cytokine release inhibitor
10/05/2010US7807703 Herbicides; pesticides
10/05/2010US7807669 Peroxisome proliferator-activated receptor type gamma (PPAR- gamma) modulators such as (S)-3-{3'-[(benzoylmethylamino)methyl]biphenyl-4-yl}-2-(1-methyl-3-oxo-3-phenylpropenylamino)propionic acid, suited for use in dermatology, immunology, cardiovascular diseases and/or hyperlipemia
10/05/2010CA2441331C Bicyclic guanidine derivatives and therapeutic uses thereof
10/05/2010CA2407967C Tubulin binding ligands and corresponding prodrug constructs
10/05/2010CA2400479C Platelet adp receptor inhibitors
09/2010
09/30/2010WO2010110479A1 Activator for peroxisome proliferator-activated receptor
09/30/2010WO2010108902A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010WO2010108856A1 Leukotriene b4 inhibitors
09/30/2010US20100249435 Polymorphs of enantiopure erdosteine
09/30/2010US20100249262 Oxime ester compound and photopolymerization initiator containing the same
09/30/2010US20100249197 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
09/30/2010US20100249165 Pdz domain modulators
09/30/2010US20100249139 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249123 Novel benzamide derivatives as modulators of the follicle stimulating hormone
09/30/2010US20100249118 Compounds and methods for kinase modulation, and indications therefor
09/30/2010US20100247468 Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
09/30/2010CA2754184A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010CA2747327A1 Leukotriene b4 inhibitors
09/29/2010EP2233468A1 Optically active dinickel complex and method for producing optically active amine using the optically active dinickel complex as catalyst
09/29/2010EP2233459A1 Method for producing conjugated aromatic compound
09/29/2010EP2231162A1 Substituted cyclopentanes having prostaglandin activity
09/29/2010EP1675824B1 Somatostatin receptor 1 and/or 4 selective agonists and antagonists
09/29/2010EP1421074B1 Novel compounds
09/29/2010CN1860364B Fluorescently tagged ligands
09/29/2010CN101848899A N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators
09/29/2010CN101844958A Method for synthesizing optical active secondary aryl alcohol by using asymmetric catalysis method
09/28/2010US7803944 Viral polymerase inhibitors
09/28/2010US7803841 EP2 receptor agonists
09/28/2010US7803800 Histone deacetylases inhibitors
09/28/2010US7803798 useful in treating vision defects, inflammatory bowel disease, alopecia, the stimulation of hair growth and the stimulation of the conversion of vellus hair to terminal hair
09/28/2010US7803797 Substituted arylcyclopentenes as therapeutic agents
09/28/2010CA2565582C Threaded connection for oil field applications
09/28/2010CA2383524C Thiazolyl alkynyl compounds and methods of use thereof
09/23/2010WO2010107997A1 Thiophenyl sulfonamides for the treatment of alzheimer's disease
09/23/2010WO2010106269A2 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics
09/23/2010WO2010105930A1 Carbamate derivatives in particular for the treatment of neurological disorders
09/23/2010WO2010083872A3 Materials for organic electroluminescence devices
09/23/2010US20100240911 Process for the preparation of N-monosubstituted beta-amino alcohols
09/23/2010US20100240904 Processes for the preparation of n-(2-acetyl-4,6-dimethylphenyl)-3--2-thiophenecarboxamide
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 329